ORIGINAL ARTICLES
(1) Felts JM, Bucks DAW: Selective release of extrahepatic lipoprotein lipase by polymetaphosphate. Biochemical and Biophysical Research Communications Vol. 102, No. 3: 1034-1040 (1981)
(2) Bucks D, Maibach H: Measurement of low level carbon-14 in biologic specimens by wet ashing. Arch. Dermatol. Res. Vol. 271: 241-244 (1981)
(3) Wester RC, Maibach HI, Bucks DAW, and Guy RH: Malathion percutaneous absorption after repeated administration to man. Toxicology And Applied Pharmacology Vol. 68:116-119 (1983)
(4) Wester RC, Bucks DAW, and Maibach HI: In vivo percutaneous absorption of hydrocortisone in psoriatic patients and normal volunteers. J. Am. Acad. Dermatol. Vol. 8:645-647 (1983)
(5) Bucks DAW, Maibach HI, Menczel E, and Wester RC: Percutaneous penetration of hydrocortisone in humans following skin delipidization by 1:1:1 triclorethane. Arch. Dermatol. Res. Vol. 275:242-245 (1983)
(6) Menczel E, Bucks D, Maibach H, and Wester R: Malathion binding to sections of human skin: skin capacity and isotherm determinations. Arch. Dermatol. Res. Vol. 275:403-406 (1983)
(7) Young D, Nacht S, Bucks D, and Maibach HI: Benzoyl peroxide: percutaneous penetration and metabolic disposition. II. effect of concentration. J. Am. Acad. Dermatol. Vol. 9:920-924 (1983)
(8) Wester RC, Bucks DAW, Maibach HI, and Anderson J: Polychlorinated biphenyls (PCBs): dermal absorption, systemic elimination, and dermal wash efficiency. Toxicol. Appl. Pharmacol. Vol. 12:511-519 (1983)
(9) Bucks DAW: Skin structure and metabolism: relevance to the design of cutaneous therapeutics. Pharm. Res. No. 4:148-153 (1984)
(10) Menczel E, Bucks D, Maibach H, and Wester R: Lindane binding to sections of human skin: skin capacity and isotherm determinations. Arch. Dermatol. Res. Vol. 276:326-329 (1984)
(11) Wester RC, Maibach HI, Bucks DAW, and Aufrere MB: In vivo percutaneous absorption of paraquat from hand, leg, and forearm of humans. Journal of Toxicology and Environmental Health Vol. 14:759-762 (1984)
(12) Bronaugh RL, Stewart RF, Wester RC, Bucks D, Maibach HI, and Anderson J: Comparison of percutaneous absorption of fragrances by humans and monkeys. Fd Chem. Toxicol. Vol. 23, No. 1:111-114 (1985)
(13) Bucks DA, Marty JPL, and Maibach: Percutaneous absorption of malathion in the guinea pig: effect of repeated skin application. Fd Chem. Toxic. Vol. 23 No. 10:919-922 (1985)
(14) Bucks DAW, Maibach HI, and Guy RH: Percutaneous absorption of steroids: effect of repeated application. J. Pharm. Sci. Vol. 74, No. 12:1337-1339 (1985)
(15) Courtheoux S, Pechnenot D, Bucks DA, Marty JPL, Maibach HI, and Wepierre J: Effect of repeated skin administration on in vivo percutaneous absorption of drugs. Brit. J. Dermatol. 115, Suppl. 31:49-52 (1986)
(16) Guy RH, Carlstrom EM, Bucks DAW, Hinz RS, and Maibach HI: Percutaneous penetration of nicotinates: in vivo and in vitro measurements and analysis. J. Pharm. Sci. Vol. 75, No. 10:968-972 (1986)
(17) Guy RH, Hadgraft J, and Bucks DAW: Transdermal drug delivery and cutaneous metabolism. Xenobiotica Vol. 17, No. 3:325-343 (1987)
(18) Kim HO, Wester RC, McMaster JR, Bucks DAW, and Maibach HI: Skin absorption from patch test systems. Contact Dermatitis Vol. 17:178-180 (1987)
(19) Bucks DAW, McMaster JR, Guy RH, and Maibach HI: Percutaneous absorption of hydroquinone in humans: effect of 1-Dodecylazacycloheptan-2-one (Azone) and the 2-Ethylhexyl ester of 4-(Dimethylamino) benzoic acid (Escalol 507). J. Tox. Environ. Health 24:279-289 (1988)
(20) Bucks DAW, Maibach HI, and Guy RH: Mass balance and dose accountability in percutaneous absorption studies: development of non-occlusive application system. Pharm. Res. 5:313-315 (1988)
(21) Bucks DAW, McMaster JR, Maibach HI, and Guy RH: Bioavailability of topically administered steroids: a "mass balance" technique. J. Invest. Dermatol. 90: 29-33 (1988)
(22) Bucks DAW, Wester RC, Mobayan MM, Maibach HI, and Coleman D: In vitro percutaneous absorption and stratum corneum binding of alachlor in lasso: effect of vehicle dilution with water. Toxicol. Appl. Pharmacol. Vol. 100:417-423 (1988)
(23) Bucks DAW, Guy RH, and Maibach HI: Percutaneous penetration and mass balance accountability: technique and implications for dermatology. J. Toxicol.-Cut. & Ocular Toxicol. 9:439-451 (1989/1990)
(24) Bucks DAW, Hinz RS, Sarason R, and Guy RH: In vivo percutaneous absorption of chemicals: a multiple dose study in rhesus monkeys. Fd Chem. Toxicol. 28:129-132 (1990)
(25) Bronaugh RL, Wester RC, Bucks DAW, Maibach HI, and Sarason R: In vivo percutaneous absorption of fragrance ingredients in rhesus monkeys and humans. Fd Chem. Toxicol. 28:369-373 (1990)
(26) Wester RC, Maibach HI, Bucks DAW, Sedik L, Melendres J, Liao C, and DiZio S: Percutaneous absorption of [14C] DDT and [14C] benzo(a)pyrene from soil. Fundam. Appl. Toxicol. 15:510-516 (1990)
(27) Wester RC, Maibach HI, Bucks DAW, McMaster J, Mobayen M, Sarason R, and Moore A: Percutaneous absorption and decontamination of PCBs. In vitro studies with human skin and in vivo studies in the rhesus monkey. J. Toxicol. Environ. Health 31:235-246 (1990)
(28) Melendres JL, Bucks DAW, Camel E, Wester RC, and Maibach HI: In vivo percutaneous absorption of hydrocortisone: Multiple-application dosing in man. Pharm. Res. 9:1164-1167 (1992)
(29) Tagawa M, Murata T, Onuma T, Kameyama K, Sakai C, Kondo S, Kozo Y, Quigley J, Dorsky A, Bucks D, and Blanock K: Inhibitory effects of magnesium ascorbyl phosphate on melanogenesis. IFSCC, Yokohama, Japan, B210:896-907 (1992)
(30) Bucks DAW, Hostynek JJ, Hinz RS, and Guy RH: Uptake of two zwitterionic surfactants into human skin in vivo. Toxicol. Appl. Pharmacol. Vol. 120:224-227 (1993)
(31) Wester RC, Bucks DAW, and Maibach HI: Human in vivo percutaneous absorption of pyrethrin and piperonyl butoxide. Fd Chem. Toxic. Vol. 32:51-53 (1994)
(32) Kameyma K, Sakai C, Kondoh S, Yonemoto K, Nishiyama S, Tagawa M, Murata T, Ohnuma T, Quigley J, Dorsky A, Bucks D, and Blanock K: Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VCPMG) on melanogenesis in vitro and in vivo. J. Am. Acad. Dermatol. 34:29-33 (1996)
(33) Oriba HA, Bucks DAW, and Maibach HI: Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of menopause and site. British Journal of Dermatology 134:229-233 (1996)
(34) Hisiore G and Bucks D: An unexpected finding in percutaneous absorption observed between haired and hairless guinea pig skin. J. Pharm. Sci. 86:398-400 (1997)
(35) Neimiec SM, Wu H-L, Jayaraman S, Hisiore G, Bucks D, Ramachandran C, and Weiner N: Effect of polyolprepolymer on the deposition of retinoic acid in various strata of hamster ear following topical in vivo application of gel formulations: correlation with deposition in human skin. Drug Delivery 4:33-36 (1997)
(36) Skov M and Bucks D: Topical delivery system for tretinoin: research and clinical implications. J. Pharm. Sci. 86:1138-1143 (1997)
(37) Quigley JW and Bucks DAW: Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: a summary of preclinical and clinical investigations. J Am Acad Dermatol 38:S5-10 (1998)
(38) Lim K-C, Sun E, Bahgat M, Bucks D, Guy R, Hinz RS, Cullander C, and McKerrow JH: Blockage of skin invasion by schistosome cercariae by serine protease inhibitors. Am J Trop Med Hyg 60:487-492 (1999)
(39) Gupta AK, Yokou M, Arika T, and Bucks D: Evaluation of the in vitro and in vivo efficacy of butenafine hydrochloride cream 1% against Malassezia furfur species and seborrheic dermatitis. Journal of Dermatological Treatment 11:79-83 (2000)
(40) Witt, K and Bucks D: Studying in vitro skin penetration and drug release to optimize dermatological formulations. Pharmaceutical Technology Supplement: Formulation, Fill & Finish 2003 22-27 (2003)
(41) Hughes-Formella B and Bucks D: Topical drug development: formulation through preclinic. World Pharma Network 31-33 July (2007)
(42) Bucks D: Skin penetration studies: Rationale & design of studies to screen & identify promising topical formulations. Drug Delivery Technology 44-47 September (2008)
(43) Bucks D, Sarpotdar P, Yu K, Angel A, and Del Rosso J: The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. Journal of Drugs in Dermatology 8:634-638 (2009)
(44) Bucks D, Pillai R, and McCall-Perez F: Advances in formulation technologies: creating highly effective and well-tolerated topical dermatologicals. Skin and Aging, July Supplement 4-6 (2010)
PUBLICATIONS
ARTICLES AND CHAPTERS IN BOOKS
(1) Bucks DAW, Bowen ST: The naupliar hemoglobins of three populations of artemia, in Bagshaw JC, Warner AH (eds.): Biochemistry Of Artemia Development. Microfilms International, Michigan, pp 100-112 (1979)
(2) Bucks DAW: Kinetics of Lipoprotein Lipase. Thesis accepted for the Master of Arts in Biology: Cell and Molecular Biology degree at San Francisco State University. (1984)
(3) Menzcel E, Bucks D, Wester RC, and Maibach HI: Skin binding during percutaneous absorption, in Bronaugh R, Maibach H (eds.): Percutaneous Absorption. Marcel Dekker Inc., New York, pp 43-56 (1985)
(4) Wester RC, Maibach HI, Surinchak J, and Bucks DAW: Predictability of in vitro diffusion systems: effect of skin types and ages in percutaneous absorption of triclocarban, in Bronaugh R, Maibach H (eds.): Percutaneous Absorption. Marcel Dekker Inc., New York, pp 223-226 (1985)
(5) Wester RC, Maibach HI, Bucks DAW, and Aufrere MB: In vivo percutaneous absorption of paraquat from hands, legs, and forearm of man, in Bronaugh R, Maibach H (eds.): Percutaneous Absorption. Marcel Dekker Inc., New York, pp 227-230 (1985)
(6) McMaster J, Maibach HI, Wester RC, and Bucks DAW: Does rubbing enhance in vivo dermal absorption? in Bronaugh R, Maibach H (eds.): Percutaneous Absorption. Marcel Dekker Inc., New York, pp 359-361 (1985)
(7) Wester RC, Bucks DAW, Maibach HI, and Anderson J: Polychlorinated biphenyls: dermal absorption, systemic elimination, and dermal wash efficiency, in Bronaugh R, Maibach H (eds.): Percutaneous Absorption. Marcel Dekker Inc., New York, pp 363-372 (1985)
(8) Wester R, Mobayen M, Ryatt K, Bucks D., and Maibach H: In vivo absorption of dithranol in psoriatic and normal volunteers, in Farber EM, Nall L, Morhenn V, and Jacobs PH (eds.): PSORIASIS Proceedings of the Fourth International Symposium. Elsevier, New York, pg 429 (1987)
(9) Guy RH, Hadgraft J, Hinz RS, Roskos KV, and Bucks DAW: Transdermal controlled systemic medications, in Chien YW (ed.): In Vivo Evaluations Of Transdermal Drug Delivery. Marcel Dekker, Inc., New York, pp 179-224 (1987)
(10) Guy RH, Bucks DAW, McMaster JR, Villaflor DA, Roskos KV, Hinz RS, and Maibach HI: Kinetics of drug absorption across human skin in vivo in Shroot B and Schaefer H (eds.): Pharmacology and the Skin, Vol. 1, Skin Pharmacokinetics. Karger, New York, pp 70-76 (1987)
(11) Wester RC, McMaster J, Bucks DAW, Bellet EM, and Maibach HI: Percutaneous absorption in rhesus monkeys and estimation of human chemical exposure, in Wang RGM, Franklin CA, Honeycut RC, and Reinert JC (eds.): Biological Monitoring for Pesticide Exposure. American Chemical Society, Washington, DC, pp 152-157 (1989)
(12) Bucks DAW: Prediction of Percutaneous Absorption. Thesis accepted for the Ph.D. in pharmaceutical chemistry: Pharmaceutical chemistry degree at University of California at San Francisco. (1989)
(13) Bucks DAW, Maibach HI, and Guy RH: Occlusion does not uniformly enhance penetration in vivo. in Bronough R and Maibach H (eds.): Percutaneous Absorption, Vol. 2. Marcel Dekker Inc., New York, pp 77-93 (1989)
(14) Marty JPL, Bucks DAW, and Maibach HI: Non invasive radioisotope counting on skin: surface or external counting? in Bronough R and Maibach H (eds.): Percutaneous Absorption, Vol. 2. Marcel Dekker Inc., New York, pp 435-442 (1989)
(15) Wester RC, Kim HO, McMaster J, Bucks DAW, and Maibach HI: Skin absorption from patch test systems: relevance to allergic contact dermatitis and transdermal delivery. in Bronough R and Maibach H (eds.):Percutaneous Absorption, Vol. 2 Marcel Dekker Inc., New York, pp 461-463 (1989)
(16) Bucks DAW, Maibach HI, and Guy RH: In vivo percutaneous absorption: Effect of repeated application versus single dose. in Bronough R and Maibach H (eds.): Percutaneous Absorption, Vol. 2 Marcel Dekker Inc., New York, pp 633-651 (1989)
(17) Bucks DAW and Maibach HI: In vivo percutaneous absorption of 5-methoxypsoralen (5-MOP) and 8-methoxypsoralen (8-MOP) in man and rhesus monkey. in Fitzpatrick TB, Forlot P, Pathak MA, and Urbach F (eds.): Psoralens: Past, Present and Future of Photochemoprotection and other Biological Activities, John Libbey Eurotext, Paris, pp 111-116 (1989)
(18) Bucks DAW: Predictive Approaches II: "Mass Balance" Procedures. AAPS/FDA/AAD/SPS/USAEHA Workshop: In Vivo Percutaneous Penetration and Absorption. Washington, D.C. May 1-3 (1989)
(19) Wester RC, Maibach HI, and Bucks DAW: Letters to the editor. Human Toxicol. 8:251-252 (1989)
(20) Oriba HA and Bucks DAW: Topical corticosteroid compounding (letter to the editor). Journal of the American Academy of Dermatology 23:954 (1990)
(21) Bucks D, Guy R, and Maibach H: Effect of Occlusion. in Bronaugh RL and Maibach HI (eds.): In Vitro Percutaneous Absorption: Principles, Fundamentals, and Applications, CRC Press, Inc., Florida, pp 85-114 (1991)
(22) Wester R, Bucks D, and Maibach H: In vitro percutaneous absorption of alachlor and atrazine. in Bronaugh RL and Maibach HI (eds.): In Vitro Percutaneous Absorption: Principles, Fundamentals, and Applications, CRC Press, Inc., Florida, pp 187-198 (1991)
(23) Bucks D, Wester R, and Maibach H: Percutaneous penetration from soil: inhibition or enhancement?. in Bronaugh RL and Maibach HI (eds.): In Vitro Percutaneous Absorption: Principles, Fundamentals, and Applications, CRC Press, Inc., Florida, pp 223-230 (1991)
(24) Wester RC, Bucks DAW, and Maibach HI: Percutaneous absorption of hazardous substances from soil. in Marzulli FN and Maibach HI (eds.): Dermatotoxicology, Fourth Edition, Hemisphere Publishing Corp., New York, pp 111-122 (1991)
(25) Wester RC, Bucks DAW, and Maibach HI: Percutaneous absorption of contaminants from soil. in Wang RG, Knaak JB and Maibach HI (eds.): Health Risk Assessment: Dermal and Inhalation Exposure and Absorption of Toxicants, CRC Press, Inc., Florida, pp 145-155 (1993)
(26) Bucks DAW: Predictive Approaches II: Mass-Balance Procedure. in Shah VP and Maibach HI (eds.):Topical Drug Bioavailability, Bioequivalence, and Penetration, Plenum Press, New York (1993)
(27) Bucks D and Maibach H: Occlusion does not uniformly enhance penetration in vivo. in Bronaugh RL and Maibach HI (eds.): Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, and Methodology Vol 3, Marcel Dekker, Inc., New York (1999)
(28) Bucks D and Maibach H: Occlusion does not uniformly enhance penetration in vivo. in Bronaugh RL and Maibach HI (eds.): Topical Absorption of Dermatological Products, Marcel Dekker, Inc., New York (2002)
(29) Bucks D and Maibach H: Occlusion does not uniformly enhance penetration in vivo. in Bronaugh RL and Maibach HI (eds.): Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, and Methodology Vol 4, Marcel Dekker, Inc., New York (2005)
(30) Bucks D: Permeability through diseased and damaged skin. in Walters KA and Roberts MS (eds.):Dermatological and Cosmeceutical Development: Therapeutic and Novel Approaches Informa Healthcare USA, Inc., New York (2008)